Ypsomed and Sidekick partner on digital obesity management solution

USA—Ypsomed, a Swiss medical device manufacturer, has partnered with Sidekick Health, a digital therapeutics company, to launch an innovative digital health solution to improve obesity management.

This collaboration seeks to improve the support of obese individuals by combining Ypsomed’s cutting-edge autoinjectors with Sidekick’s extensive digital health app.

The solution integrates Ypsomed’s SmartPilot—a smart add-on for YpsoMate autoinjectors—with Sidekick’s app, which offers digital health and chronic condition support.

This integration empowers patients using GLP-1-based injectable therapies to manage their treatments more effectively.

The SmartPilot captures real-time injection data, including the timing, duration, and accuracy of each administration, which is crucial for helping patients stick to their medication schedules.

Meanwhile, the Sidekick app provides comprehensive disease education and self-care support, tackling the various challenges of managing obesity.

Obesity is a complex, chronic condition impacting millions globally. Although GLP-1 therapies hold substantial promise for weight loss and reducing cardiometabolic risks, many patients encounter difficulties in self-care management.

Common hurdles include coping with side effects understanding their condition, and adhering to medication titration schedules, often resulting in patients failing to achieve their therapeutic goals and limiting the effectiveness of GLP-1 therapies.

The integrated Ypsomed-Sidekick solution aims to help patients unlock the full benefits of GLP-1 therapies by improving adherence and persistence, leading to sustained weight loss and lower cardiovascular and metabolic risks.

This comprehensive approach includes patient education resources that help individuals understand obesity, navigate medication titration, and set realistic expectations for their treatment outcomes.

Additionally, the solution provides lifestyle and behavioral support, with personalized content designed to guide patients throughout their treatment journey.

 This includes tools for tracking symptoms, nutritional advice, physical activity coaching, and strategies for improving sleep and managing stress.

Injection support is also featured, with a user-friendly guide that simplifies and optimizes the injection process through reminders, step-by-step instructions, feedback on injection accuracy, and help with needle-related concerns.

This solution establishes a robust technical platform, enabling pharmaceutical companies to enhance patient experiences by seamlessly integrating therapy and injection methods while tracking patient behavior.

Ypsomed’s smart devices gather real-time adherence data, yielding high-quality real-world information that can refine treatment strategies for obesity.

Ulrike Bauer, Chief Business Officer of Ypsomed Delivery Systems, noted that collaborating with Sidekick Health empowers patients through knowledge, real-time insights, and improved therapy management to enhance long-term health outcomes.

 By linking smart injection devices, real-time data can be collected to track therapies, enabling pharmaceutical partners to advance obesity treatments continually.

Dr. Tryggvi Thorgeirsson, CEO of Sidekick Health, highlighted that this partnership demonstrates their shared commitment to using technology to address significant gaps in the management of chronic conditions.

Their goal is to transform the treatment journeys for individuals affected by obesity, ultimately resulting in improved patient outcomes.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.